Dr Reddys Laboratories Q1 PAT seen up 73.7% YoY to Rs 912.4 cr: Nirmal Bang

Nirmal Bang has come out with its first quarter (April - June’ 24) earnings estimates for the Pharmaceutical sector. The brokerage house expects Dr Reddys Laboratories to report net profit at Rs 912.4 crore up 73.7% year-on-year (down 4.9% quarter-on-quarter).

Net Sales are expected to increase by 22.3 percent Y-o-Y (down 3.1 percent Q-o-Q) to Rs 6,099.1 crore, according to Nirmal Bang.

Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 102.2 percent Y-o-Y (down 8.2 percent Q-o-Q) to Rs 1,402.8 crore.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.